AUC

:   area under the ROC curve

CDC20

:   cell division cycle protein 20

DElncRNA

:   differentially expressed lncRNA

DEmiRNA

:   differentially expressed miRNA

DEmRNA

:   differentially expressed mRNA

EEC

:   endometrioid endometrial carcinoma

EPCAM

:   epithelial cell adhesion molecule

FC

:   fold change

FDR

:   false discovery rate

GO

:   Gene Ontology

HCC

:   hepatocellular carcinoma

HSC

:   hepatic stellate cell

KEGG

:   Kyoto Encyclopedia of Genes and Genomes

KIFC1

:   kinesin family member C1

lncRNA

:   long non‐coding RNA

LRAT

:   lecithin retinol acyltransferase

miRNA

:   microRNA

RCAN1

:   regulator of calcineurin 1

RND3

:   Rho family GTPase 3

TCGA

:   The Cancer Genome Atlas

Human hepatocellular carcinoma (HCC) is the fifth most common cancer as well as the third leading cause of cancer‐related mortality worldwide [1](#feb412483-bib-0001){ref-type="ref"}. It is a highly aggressive cancer that is characterized by fast infiltrating growth, early metastasis, high‐grade malignancy and poor prognosis [2](#feb412483-bib-0002){ref-type="ref"}. Only around 10--20% of patients with HCC are diagnosed at the early stage due to lack of effective diagnostic approaches [3](#feb412483-bib-0003){ref-type="ref"}, [4](#feb412483-bib-0004){ref-type="ref"}. Moreover, the long‐term overall survival rate remains rather low despite various therapeutic strategies for HCC having been developed [5](#feb412483-bib-0005){ref-type="ref"}. Hence, it is crucial to elucidate the mechanism and develop accurate diagnostic biomarkers and effective therapeutic strategies for HCC.

Previous studies have identified risk factors of HCC such as chronic infection with hepatitis B virus and hepatitis C virus, hepatocirrhosis induced by alcohol, other chronic inflammatory‐related factors and hepatic regenerative changes [6](#feb412483-bib-0006){ref-type="ref"}, [7](#feb412483-bib-0007){ref-type="ref"}, [8](#feb412483-bib-0008){ref-type="ref"}. However, the molecular mechanism of HCC remains largely unknown. Aberrantly expressed genes such as *RND3*,*LRAT*,*ECHS1*,*ACAA1*,*MT2A* and *MYC* have been demonstrated to be associated with the pathogenesis of HCC [9](#feb412483-bib-0009){ref-type="ref"}, [10](#feb412483-bib-0010){ref-type="ref"}, [11](#feb412483-bib-0011){ref-type="ref"}. In addition, accumulated evidence has demonstrated that aberrantly expressed microRNAs (miRNAs), such as miR‐21, miR‐93, miR‐424, miR‐181b, miR‐221, miR‐222 and miR‐122, were associated with the development and progression of HCC [12](#feb412483-bib-0012){ref-type="ref"}, [13](#feb412483-bib-0013){ref-type="ref"}, [14](#feb412483-bib-0014){ref-type="ref"}. Long non‐coding RNAs (lncRNAs) are a class of conserved non‐protein‐coding RNAs with more than 200 nucleotides that are broadly distributed in the human genome [15](#feb412483-bib-0015){ref-type="ref"}. They involve many biological processes and could regulate gene expression in *cis* or in *trans* by diverse mechanisms [16](#feb412483-bib-0016){ref-type="ref"}. They were reported to play key roles in various cancers such as colorectal cancer, breast cancer and HCC [17](#feb412483-bib-0017){ref-type="ref"}, [18](#feb412483-bib-0018){ref-type="ref"}, [19](#feb412483-bib-0019){ref-type="ref"}. However, only a handful of HCC‐associated lncRNAs, such as HULC, HOTAIR, MEG3, MVIH and MTIDP, have been investigated [17](#feb412483-bib-0017){ref-type="ref"}, [18](#feb412483-bib-0018){ref-type="ref"}. To better understand the mechanism of HCC, it is crucial to identify key genes, miRNAs and lncRNAs in HCC. Moreover, many previous studies focused on revealing the functions of each individual gene, miRNA and lncRNA in the process of HCC, and hence mechanistic relationships among them remain largely unknown.

In this study, comprehensive analysis of mRNA, miRNA and lncRNA profiling data of HCC from The Cancer Genome Atlas (TCGA) was performed. We identified differentially expressed mRNAs (DEmRNAs), miRNAs (DEmiRNAs) and lncRNAs (DElncRNAs) in HCC. Based on bioinformatics analysis, interactions among DEmRNAs, DEmiRNAs and DElncRNAs were analyzed. Receiver operating characteristic (ROC) and survival analyses were performed to access the diagnostic and prognostic value of selected DElncRNAs, DEmRNAs and DEmiRNAs for HCC. Our study may provide new clues for exploring molecular mechanisms of HCC and developing HCC‐associated diagnostic and therapeutic approaches.

Materials and methods {#feb412483-sec-0002}
=====================

mRNA, miRNA and lncRNA profiles of HCC in TCGA {#feb412483-sec-0003}
----------------------------------------------

The Cancer Genome Atlas is a central bank for multidimensional data of various cancers at DNA, RNA and protein levels. In this study, the clinical information of patients with HCC was downloaded from TCGA data portal (<http://tcga-data.nci.nih.gov/>). [rsem]{.smallcaps}‐normalized mRNA and lncRNA expression profiles (Level 3‐IlluminaHiseq_RNASeqV2 data) and miRNA expression profile (Level 3‐IlluminaHiSeq‐miRNASeq data) between HCC and adjacent normal tissues were downloaded from TCGA data portal (<http://tcga-data.nci.nih.gov/>) as well.

DEmRNAs, DEmiRNAs and DElncRNAs in HCC compared with adjacent tissues {#feb412483-sec-0004}
---------------------------------------------------------------------

Before identifying the DEmRNAs, DEmiRNAs and DElncRNAs between HCC and normal tissues, we firstly filtered the difficultly detected miRNAs, mRNAs and lncRNAs (miRNAs, mRNAs and lncRNAs with read count value = 0 in more than 10% of HCC cases or in more than 10% of normal tissues).

Then, based on the read count of each sample, the DEmRNAs and DEmiRNAs in HCC compared with adjacent tissues were calculated with the R‐bioconductor package [deseq2]{.smallcaps} [20](#feb412483-bib-0020){ref-type="ref"} with false discovery rate (FDR) \< 0.01 and abs \[log2 fold change (FC)\] \> 1.5. Based on the BAM files, we used reads per kilobase per million reads (RPKM) to quantify the expression levels of lncRNAs. Student\'s *t* test was performed to obtain *P* values. Using the Benjamini and Hochberg method, multiple comparisons were performed to obtain the FDR [21](#feb412483-bib-0021){ref-type="ref"}. The threshold for the DElncRNAs was FDR \< 0.01 and abs (log2 FC) \> 1.5 as well.

Functional annotation of DEmRNAs between HCC and normal tissues {#feb412483-sec-0005}
---------------------------------------------------------------

Functional annotation, including Gene Ontology (GO) classification and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of DEmRNAs between HCC and normal tissues, was conducted using online software [genecodis]{.smallcaps} (<http://genecodis.cnb.csic.es/analysis>). Statistical significance was defined as FDR \< 0.05.

HCC‐specific DEmiRNA--DEmRNA interaction network {#feb412483-sec-0006}
------------------------------------------------

Firstly, pairwise Pearson correlation coefficients between DEmRNAs and DEmiRNAs were calculated. DEmiRNA--DEmRNA pairs with *P* \< 0.05 and *r* \< 0 were served as significant negative DEmiRNA--DEmRNA co‐expression pairs. Then, the putative targeted DEmRNAs of DEmiRNAs were predicted by six bioinformatic algorithms ([rna22]{.smallcaps},[miranda]{.smallcaps},[mirdb]{.smallcaps},[mirwalk]{.smallcaps},[pictar2]{.smallcaps} and [targetscan]{.smallcaps}) of [mirwalk2.0]{.smallcaps} (<http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/mir-mir-self.html>). Targets recorded by ≥ 4 algorithms were served as target DEmRNAs of DEmiRNAs. The confirmed target DEmRNAs of DEmiRNAs were obtained by [mirwalk2.0]{.smallcaps} <http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/mir-mir-self.html> as well. Finally, DEmiRNA--DEmRNA co‐expression pairs were obtained whose DEmRNA was not only negatively co‐expressed with DEmiRNAs but also the predicted targets of this DEmiRNA with ≥ 4 algorithms or confirmed targets of this DEmiRNA. Based on these DEmiRNA--DEmRNA pairs, the DEmiRNA--DEmRNA interaction network was constructed and visualized using [cytoscape]{.smallcaps} software (<http://www.cytoscape.org/>).

HCC‐specific DElncRNA--DEmiRNA interaction network {#feb412483-sec-0007}
--------------------------------------------------

Firstly, pairwise Pearson correlation coefficients between DElncRNAs and DEmiRNAs were calculated. DElncRNA--DEmiRNA pairs with *P* \< 0.05 and *r* \< 0 were served as significant negative DElncRNA--DEmiRNA co‐expression pairs. Then, the putative targeted DElncRNAs of DEmiRNAs were predicted by miRWalk of [mirwalk2.0]{.smallcaps} <http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/mir-mir-self.html>. Finally, DElncRNA--DEmiRNA pairs whose DElncRNA was not only negatively co‐expressed with DEmiRNAs but also the predicted targets of this DEmiRNA by miRWalk were obtained. Based on these DElncRNA--DEmiRNA pairs, the DElncRNA--DEmiRNA interaction network was constructed and visualized using [cytoscape]{.smallcaps} software<http://www.cytoscape.org/>.

HCC‐specific DElncRNA--DEmiRNA--DEmRNA interaction network {#feb412483-sec-0008}
----------------------------------------------------------

The HCC‐specific DElncRNA--DEmiRNA--DEmRNA interaction network was constructed by merging the HCC‐specific DEmiRNA--DEmRNA interaction network and DElncRNA--DEmiRNA interaction network based on the common DEmiRNAs.

Nearby targeted DEmRNAs of DElncRNAs in HCC {#feb412483-sec-0009}
-------------------------------------------

To identify the target DEmRNAs of DElncRNAs by *cis*‐regulatory effects, we searched the DEmRNAs transcribed within a 200‐kb window up‐ or downstream of DElncRNAs that were served as nearby *cis*‐targeted DEmRNAs of DElncRNAs.

ROC analysis {#feb412483-sec-0010}
------------

In order to access the diagnostic value of DElncRNAs, DEmRNAs and DEmiRNAs for HCC, respectively, the [proc]{.smallcaps} package was used to calculate ROC, and the area under the ROC curve (AUC) was further calculated. When AUC value was greater than 0.8, the DElncRNAs/DEmRNAs/DEmiRNAs were considered capable of distinguishing patients with HCC and normal controls with excellent specificity and sensitivity.

Survival analysis {#feb412483-sec-0011}
-----------------

Using survival (<https://cran.r-project.org/web/packages/survival/index.html>) in R, the prognostic value of selected DElncRNAs, DEmRNAs and DEmiRNAs for patients with HCC was analyzed.

Results {#feb412483-sec-0012}
=======

DEmRNAs, DEmiRNAs and DElncRNAs in HCC {#feb412483-sec-0013}
--------------------------------------

Data for a total of 377 patients with HCC were downloaded from TCGA data portal. From these there were obtained the mRNA expression profile of HCC tissues of 371 patients with HCC and 50 adjacent tissues, the miRNA expression profile of HCC tissues of 372 patients with HCC and 50 adjacent tissues and the lncRNA expression profile of HCC tissues of 200 patients with HCC and 50 adjacent tissues.

After filtering the difficultly detected miRNAs, mRNAs and lncRNAs, a total of 311 miRNAs, 14 607 mRNAs and 2152 lncRNAs were retained for analysis. A total of 1239 DEmRNAs (865 of them upregulated and 374 of them downregulated), 33 DEmiRNAs (29 upregulated and four downregulated) and 167 DElncRNAs (165 upregulated and two downregulated) in HCC were obtained. A heat‐map of DEmRNAs, DEmiRNAs and DElncRNAs in HCC is displayed in Fig. [1](#feb412483-fig-0001){ref-type="fig"}. The top 10 up‐ and downregulated DEmRNAs and DEmiRNAs, and the top 20 DElncRNAs between HCC and normal tissues are displayed in Tables [1](#feb412483-tbl-0001){ref-type="table"}, [2](#feb412483-tbl-0002){ref-type="table"}, [3](#feb412483-tbl-0003){ref-type="table"}, respectively.

![Hierarchical clustering analysis of the DEmRNAs, DEmiRNAs and DElncRNAs in HCC and adjacent normal tissues. Rows and columns represent samples and DEmRNAs, DEmiRNAs, and DElncRNAs, respectively. Red and green represent up‐ and downregulation, respectively. Case: HCC tissues; control: adjacent normal tissues. (A) Hierarchical clustering analysis of the top 50 DEmRNAs in HCC; (B) hierarchical clustering analysis of the DEmiRNAs in HCC; (C) hierarchical clustering analysis of the top 50 DElncRNAs in HCC.](FEB4-8-1424-g001){#feb412483-fig-0001}

###### 

Top 10 up‐ and downregulated DEmRNAs between HCC and normal tissues

  Gene ID   Symbol       Log FC   *P* value   FDR         Regulation
  --------- ------------ -------- ----------- ----------- ------------
  1033      *CDKN3*      4.40     1.02E‐106   1.50E‐102   Up
  83540     *NUF2*       4.77     9.25E‐102   6.76E‐98    Up
  1306      *COL15A1*    4.28     2.30E‐100   1.12E‐96    Up
  83483     *PLVAP*      2.89     1.82E‐98    6.66E‐95    Up
  24137     *KIF4A*      4.35     7.46E‐96    2.18E‐92    Up
  29089     *UBE2T*      3.43     1.02E‐94    2.47E‐91    Up
  1063      *CENPF*      3.94     3.91E‐93    8.17E‐90    Up
  3833      *KIFC1*      3.96     5.94E‐93    1.08E‐89    Up
  9833      *MELK*       4.17     2.48E‐90    4.02E‐87    Up
  11004     *KIF2C*      4.38     5.64E‐90    8.24E‐87    Up
  11093     *ADAMTS13*   −2.90    1.25E‐77    4.95E‐75    Down
  170392    *OIT3*       −3.56    2.08E‐73    6.19E‐71    Down
  64651     *CSRNP1*     −2.24    6.54E‐60    1.02E‐57    Down
  1893      *ECM1*       −3.02    2.44E‐54    3.05E‐52    Down
  1827      *RCAN1*      −2.39    9.08E‐53    1.05E‐50    Down
  5199      *CFP*        −3.33    6.69E‐52    7.40E‐50    Down
  390       *RND3*       −2.47    2.22E‐51    2.35E‐49    Down
  83854     *ANGPTL6*    −3.02    7.92E‐49    7.51E‐47    Down
  7538      *ZFP36*      −2.15    6.23E‐47    5.42E‐45    Down
  9227      *LRAT*       −3.22    2.35E‐45    1.82E‐43    Down
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###### 

DEmiRNAs between HCC and normal tissues

  DEmiRNA         Log FC   *P* value   FDR        Regulation
  --------------- -------- ----------- ---------- ------------
  hsa‐mir‐424     −2.21    5.92E‐61    1.84E‐58   Down
  hsa‐mir‐10b     3.59     6.75E‐59    1.05E‐56   Up
  hsa‐mir‐21      1.84     6.65E‐55    6.89E‐53   Up
  hsa‐mir‐93      1.71     2.22E‐51    1.73E‐49   Up
  hsa‐mir‐589     1.58     1.89E‐50    1.18E‐48   Up
  hsa‐mir‐224     3.26     6.52E‐47    3.38E‐45   Up
  hsa‐mir‐183     3.86     2.29E‐46    1.02E‐44   Up
  hsa‐mir‐1269    5.56     8.76E‐46    3.41E‐44   Up
  hsa‐mir‐96      3.75     3.42E‐40    1.18E‐38   Up
  hsa‐mir‐500a    1.60     4.26E‐40    1.32E‐38   Up
  hsa‐mir‐182     3.37     5.13E‐39    1.45E‐37   Up
  hsa‐mir‐452     2.50     2.09E‐36    5.40E‐35   Up
  hsa‐mir‐221     1.57     5.83E‐30    1.13E‐28   Up
  hsa‐mir‐217     4.00     1.11E‐27    1.93E‐26   Up
  hsa‐mir‐1180    1.77     8.59E‐27    1.34E‐25   Up
  hsa‐mir‐9‐1     3.23     1.31E‐26    1.85E‐25   Up
  hsa‐mir‐9‐2     3.22     1.49E‐26    2.02E‐25   Up
  hsa‐mir‐196b    3.28     5.01E‐26    6.00E‐25   Up
  hsa‐mir‐1266    2.06     6.79E‐26    7.54E‐25   Up
  hsa‐mir‐3200    2.54     3.87E‐23    3.89E‐22   Up
  hsa‐mir‐877     1.80     1.04E‐21    9.26E‐21   Up
  hsa‐mir‐3677    1.65     5.26E‐21    4.42E‐20   Up
  hsa‐mir‐18a     1.67     7.16E‐20    5.57E‐19   Up
  hsa‐mir‐216a    3.45     1.48E‐19    1.10E‐18   Up
  hsa‐mir‐19a     1.55     2.90E‐19    2.05E‐18   Up
  hsa‐mir‐3607    −1.65    1.06E‐16    6.12E‐16   Down
  hsa‐mir‐1274b   −1.52    1.83E‐15    9.81E‐15   Down
  hsa‐mir‐508     2.19     6.42E‐15    3.33E‐14   Up
  hsa‐mir‐937     1.68     1.39E‐13    6.17E‐13   Up
  hsa‐mir‐1226    1.72     1.87E‐13    7.98E‐13   Up
  hsa‐mir‐3648    −1.52    2.81E‐11    1.03E‐10   Down
  hsa‐mir‐431     1.53     3.05E‐08    8.54E‐08   Up
  hsa‐mir‐483     1.79     2.02E‐05    4.29E‐05   Up
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###### 

Top 20 DElncRNAs between HCC and normal tissues

  ENSG              ID          Symbol         Log FC   *P* value   FDR        Regulation
  ----------------- ----------- -------------- -------- ----------- ---------- ------------
  ENSG00000267080   339201      ASB16‐AS1      1.52     2.51E‐38    1.80E‐35   Up
  ENSG00000212694   338799      LINC01089      2.21     5.18E‐36    1.59E‐33   Up
  ENSG00000206573   440944      THUMPD3‐AS1    1.67     1.00E‐32    1.32E‐30   Up
  ENSG00000232995   8490        RGS5           1.99     1.05E‐32    1.32E‐30   Up
  ENSG00000249592   100129917   LOC100129917   1.66     1.32E‐32    1.58E‐30   Up
  ENSG00000234608   51275       MAPKAPK5‐AS1   1.54     1.44E‐32    1.63E‐30   Up
  ENSG00000228288   100506696   PCAT6          2.34     5.79E‐31    4.29E‐29   Up
  ENSG00000228265   101926888   RALY‐AS1       1.52     3.47E‐30    2.07E‐28   Up
  ENSG00000213742   102724826   ZNF337‐AS1     1.68     3.29E‐30    2.07E‐28   Up
  ENSG00000224424   100506637   PRKAR2A‐AS1    2.26     5.79E‐30    3.20E‐28   Up
  ENSG00000172965   541471      MIR4435‐2HG    2.53     6.70E‐30    3.52E‐28   Up
  ENSG00000234912   654434      SNHG20         1.67     2.32E‐28    9.43E‐27   Up
  ENSG00000233527   101927599   ZNF529‐AS1     1.69     5.34E‐28    1.89E‐26   Up
  ENSG00000228106   102724017   LOC102724017   1.56     1.50E‐27    4.82E‐26   Up
  ENSG00000250988   100505616   SNHG21         1.78     2.56E‐27    7.66E‐26   Up
  ENSG00000226696   104355426   LENG8‐AS1      2.19     3.76E‐27    1.11E‐25   Up
  ENSG00000186615   100129075   KTN1‐AS1       1.79     1.13E‐26    2.98E‐25   Up
  ENSG00000198468   642946      FLVCR1‐AS1     2.24     1.18E‐26    3.06E‐25   Up
  ENSG00000232940   414765      HCG25          2.54     1.40E‐26    3.58E‐25   Up
  ENSG00000234432   100129484   LOC100129484   1.88     1.95E‐26    4.60E‐25   Up
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Functional annotation of DEmRNAs between HCC and normal tissues {#feb412483-sec-0014}
---------------------------------------------------------------

Functional annotation of DEmRNAs between HCC and normal tissues indicated that mitotic cell cycle (FDR = 4.56 × 10^−36^), protein binding (FDR =  2.16 × 10^−26^), and cytoplasm (FDR = 1.25 × 10^−34^) were significantly enriched GO terms (Fig. [2](#feb412483-fig-0002){ref-type="fig"}A--C). Retinol metabolism (FDR = 7.02 × 10^−14^) and metabolism of xenobiotics by cytochrome P450 (FDR = 7.30 × 10^−11^) were two significantly enriched pathways (Fig. [2](#feb412483-fig-0002){ref-type="fig"}D,E).

![Functional annotation of DEmRNAs between HCC and normal tissues. (A--D) The significantly enriched biological process (A), molecular function (B), cellular component (C) and KEGG pathways (D) for DEmRNAs between HCC and normal tissues. The *x*‐axis shows −log FDR and the *y*‐axis shows GO terms or KEGG pathways. (E) The pathway of retinol metabolism. The red and green rectangles represent the particles that are regulated by up‐ and downregulated DEmRNAs, respectively, between HCC and normal tissues.](FEB4-8-1424-g002){#feb412483-fig-0002}

HCC‐specific DEmiRNA--DEmRNA interaction network {#feb412483-sec-0015}
------------------------------------------------

Firstly, we obtained 7996 negative DEmiRNA--DEmRNA co‐expression pairs with *P* \< 0.05 and *r* \< 0. Then, a total of 1142 DEmiRNA‐target DEmRNA pairs with predicted ≥ 4 algorithms were obtained. Finally, 545 DEmiRNA--DEmRNA pairs were obtained whose DEmRNA was not only negatively co‐expressed with DEmiRNAs but also the predicted targets of this DEmiRNA with ≥ 4 algorithms. These 545 DEmiRNA--DEmRNA pairs consisted of 258 DEmRNAs (88 upregulated and 170 downregulated) and 28 DEmiRNAs (25 upregulated and three downregulated) in HCC. The HCC‐specific DEmiRNA--DEmRNA interaction network is displayed in Fig. [3](#feb412483-fig-0003){ref-type="fig"}. mir‐424 (degree = 56), miR‐93 (degree = 51), and miR‐3607 (degree = 37) are three hub DEmiRNAs.

![Hepatocellular carcinoma‐specific DEmiRNA--DEmRNA interaction network. Rhombuses and ellipses represent DEmiRNAs and DEmRNAs, respectively. Red and blue represent up‐ and downregulation, respectively.](FEB4-8-1424-g003){#feb412483-fig-0003}

HCC‐specific DElncRNA--DEmiRNA interaction network {#feb412483-sec-0016}
--------------------------------------------------

Firstly, we obtained 1258 negative DElncRNA--DEmiRNA co‐expression pairs with *P* \< 0.05 and *r* \< 0. Then, a total of 7090 DEmiRNA‐target DElncRNA pairs were obtained by [mirwalk]{.smallcaps}. Finally, we obtained 342 DEmiRNA--DElncRNA pairs whose DElncRNA was not only negatively coexpressed with DEmiRNA but also the predicted targets of this DEmiRNA based on [mirwalk]{.smallcaps}. The HCC‐specific DElncRNA--DEmiRNA interaction network consisted of 260 nodes and 342 edges (Fig. [4](#feb412483-fig-0004){ref-type="fig"}). miR‐424 (degree = 171) and miR‐3648 (degree = 11) were hub DEmiRNAs of an HCC‐specific DElncRNA--DEmiRNA interaction network.

![Hepatocellular carcinoma‐specific DEmiRNA--DElncRNA interaction network. Rhombuses and rectangles represent DEmiRNAs and DElncRNAs, respectively. Red and blue represent up‐ and downregulation, respectively.](FEB4-8-1424-g004){#feb412483-fig-0004}

HCC‐specific DElncRNA--DEmiRNA--DEmRNA interaction network {#feb412483-sec-0017}
----------------------------------------------------------

The HCC‐specific DElncRNA--DEmiRNA--DEmRNA interaction network consisted of 417 nodes and 651 edges. HAND2‐AS1/ENSG00000232855--miR‐93--lecit hin retinol acyltransferase (LRAT)/Rho family GTPase 3 (RND3), ENSG00000232855--miR‐877--regulator of calcineurin 1 (RCAN1) and ENSG00000232855--miR‐224--*RND3* interactions were found in this HCC‐specific DElncRNA--DEmiRNA--DEmRNA interaction network (Fig. [5](#feb412483-fig-0005){ref-type="fig"}).

![Hepatocellular carcinoma‐specific DEmiRNA--DElncRNA--DEmRNA interaction network. Rectangles, rhombuses and ellipses represent DElncRNAs, DEmiRNAs and DEmRNAs, respectively. Red and blue represent up‐ and downregulation, respectively.](FEB4-8-1424-g005){#feb412483-fig-0005}

Nearby targeted DEmRNAs of DElncRNAs in HCC {#feb412483-sec-0018}
-------------------------------------------

A total of three DEmRNAs transcribed within a 200‐kb window up‐ or downstream of three DElncRNAs in HCC were obtained. HCG25--*kinesin family member C1* (*KIFC1*), LOC105378687--*cell division cycle protein 20* (*CDC20*) and LOC101927043--*epithelial cell adhesion molecule* (*EPCAM*) are three DElncRNA--nearby target DEmRNA pairs (Table [4](#feb412483-tbl-0004){ref-type="table"}).

###### 

DElncRNA‐nearby targeted DEmRNA pairs in HCC. Chr, chromosome

  lncRNA   Nearby targeted mRNA                                                             
  -------- ---------------------- -------------- ---------- ---------- --------- ---------- ----------
  chr6     ENSG00000232940        HCG25          33049534   33454989   *KIFC1*   33391536   33409924
  chr1     ENSG00000234694        LOC105378687   43154684   43558658   *CDC20*   43358955   43363203
  chr2     ENSG00000234690        LOC101927043   46992405   47545074   *EPCAM*   47345158   47387601
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ROC analysis {#feb412483-sec-0019}
------------

ROC curve analysis was performed to evaluate the diagnostic value of five DElncRNAs (HAND2‐AS1, ENSG00000232855, HCG25, LOC105378687 and LOC101927043), five DEmRNAs (*RND3, LART, RCAN1, KIFC1* and *CDC20*) and four DEmiRNAs (miR‐424, miR‐93, miR‐224 and miR‐877) for HCC. Except for LOC101927043 and miR‐877, the other four DElncRNAs (HAND2‐AS1, ENSG00000232855, HCG25 and LOC105378687), five DEmRNAs (*RND3, LART, RCAN1, KIFC1* and *CDC20*) and three DEmiRNAs (miR‐424, miR‐93 and miR‐224) have great diagnostic value for HCC with AUC more than 0.8 (Fig. [6](#feb412483-fig-0006){ref-type="fig"}).

![ROC analysis of selected DEmRNAs, DEmiRNAs and DElncRNAs. ROC curves were used to show the diagnostic value of selected DElncRNAs, DEmRNAs and DEmiRNAs for HCC with sensitivity and specificity. The *x*‐axis indicates 1 − specificity, and *y*‐axis indicates sensitivity. Names of the DElncRNAs, DEmRNAs and DEmiRNAs are displayed above the ROC curve.](FEB4-8-1424-g006){#feb412483-fig-0006}

Survival analysis {#feb412483-sec-0020}
-----------------

Survival analysis was performed to evaluate the prognostic value of five DElncRNAs (HAND2‐AS1, ENSG00000232855, HCG25, LOC105378687 and LOC101927043), five DEmRNAs (*RND3, LART, RCAN1, KIFC1* and *CDC20*) and four DEmiRNAs (miR‐424, miR‐93, miR‐224 and miR‐877) for HCC. Only two DEmRNAs (*CDC20* and *KIFC1*) and miR‐877 have prognostic value for HCC. High expression of *CDC20* (*P *=* *1.03 × 10^−6^), *KIFC1* (*P *=* *8.58 × 10^−7^) and miR‐877 (*P *=* *0.0108) was significantly associated with a lower survival rate in patients with HCC (Fig. [7](#feb412483-fig-0007){ref-type="fig"}).

![Survival analysis of selected DEmRNAs, DEmiRNAs, and DElncRNAs. Survival curves were used to show the prognostic value of selected DEmRNAs and DEmiRNAs for HCC. The *x*‐axis indicated times (days), and *y*‐axis indicated survival rate. Above the survival curves, names of DEmRNAs and DEmiRNAs were displayed. High expression of CDC20 (*P *=* *1.03 × 10^−6^), KIFC1 (*P *=* *8.58 × 10^−7^), and miR‐877 (*P *=* *0.0108) were significantly associated with lower survival rate in patients with HCC.](FEB4-8-1424-g007){#feb412483-fig-0007}

Discussion {#feb412483-sec-0021}
==========

In this study, we identified DEmRNAs, DEmiRNAs and DElncRNAs between HCC and normal controls from TCGA. Their interactions and potential diagnostic and prognostic value for HCC were further examined by bioinformatics analysis.

Functional annotation of DEmRNAs indicated that retinol metabolism was a significantly enriched pathway in HCC. Retinoic acids have been demonstrated to play an inhibitory role in carcinogenesis of various cancers, including HCC [22](#feb412483-bib-0022){ref-type="ref"}. Inhibition of retinoic acid signaling in hepatocytes provoked the development of liver cancer in transgenic mice [23](#feb412483-bib-0023){ref-type="ref"}. Metabolism of xenobiotics by cytochrome P450 was another significantly enriched pathway in HCC. This is a typical liver‑function‑specific pathway and has been indicated to play crucial roles in HCC [24](#feb412483-bib-0024){ref-type="ref"}. The members of the cytochrome P450 (CYP) family have frequently been found to be involved in various biological processes that were found to be dysregulated in liver cancer [25](#feb412483-bib-0025){ref-type="ref"}. Hence, DEmRNAs enriched in these two pathways might be regulators in HCC, and this needs further research.

Our study provided evidence for several HCC‐related mRNAs identified in previous studies. Moreover, their functions in HCC were further studied by the interaction of DElncRNAs and DEmiRNAs with them. Based on the present study, miR‐424, miR‐93 and miR‐224 are three hub miRNAs of an HCC‐specific DEmiRNA--DEmRNA interaction network and all of them have great diagnostic value for HCC, suggesting their importance in HCC. Upregulated miR‐93 has been found in patients with HCC in previous studies, which is consistent with the present study [14](#feb412483-bib-0014){ref-type="ref"}. Increased miR‐93 was associated with cell migration and invasion of HCC and serves as a potential marker of poor 5‐year overall survival of patients with HCC [14](#feb412483-bib-0014){ref-type="ref"}, [26](#feb412483-bib-0026){ref-type="ref"}. Based on our DEmiRNA--DEmRNA interaction network, miR‐424, miR‐93 and miR‐224 had 56, 51 and 34 targeted DEmRNAs in HCC, respectively. RND3 was a shared target of both miR‐93 and miR‐224. LRAT was another target of miR‐93. Both *RND3* and *LRAT* are two downregulated DEmRNAs derived from the top 10 downregulated DEmRNAs and have great diagnostic value for HCC.

Previous studies have indicated that both *RND3* and *LRAT* are HCC‐related genes. RND3 is a member of the RND subfamily of the Rho GTPase family. *RND3* was significantly downregulated in HCC cell lines and tissues. HCC cell growth could be inhibited by knockdown of RND3 [10](#feb412483-bib-0010){ref-type="ref"}. *RND3* was speculated to regulate a switch to attenuate cell growth and favor cell invasion and serve as a potential metastasis suppressor gene in HCC [10](#feb412483-bib-0010){ref-type="ref"}. Retinoid is mainly stored in the liver in the form of retinyl ester in lipid droplets. Hepatic stellate cells (HSCs) serve as the major cells of retinoid storage within the liver [27](#feb412483-bib-0027){ref-type="ref"}. Lack of retinoid‐containing lipid droplets of HSCs has been observed in the development of liver disease leading to HCC [27](#feb412483-bib-0027){ref-type="ref"}. As the sole enzyme that conducts the synthesis of hepatic retinyl ester, LRAT may play a key role in the pathogenesis of HCC [11](#feb412483-bib-0011){ref-type="ref"}. Our study found that *LRAT* was downregulated in patients with HCC, which was consistent with a previous study [28](#feb412483-bib-0028){ref-type="ref"}. Taken together, miR‐93--RND3/LRAT and miR‐224--RND3 interactions may play crucial roles in HCC.

lncRNAs were reported to bind to miRNA and act as sponges for miRNAs [29](#feb412483-bib-0029){ref-type="ref"}. By sharing common miRNA binding sites with mRNA targets, lncRNAs sequester and compete with miRNA to inhibit miRNA function and alleviate mRNA repression [30](#feb412483-bib-0030){ref-type="ref"}. In the present study, we constructed the lncRNA--miRNA--mRNA interaction network based on the shared common miRNAs.

Two downregulated lncRNAs (HAND2‐AS1 and ENSG00000232855) with great diagnostic value for HCC were shared targets of both miR‐93 and miR‐244. HAND2‐AS1 transcribed antisense adjacent to heart and neural crest derivatives expressed 2 (HAND2) in chromosome 4q33‐34 [31](#feb412483-bib-0031){ref-type="ref"}. HAND2‐AS1 was reported to play an inhibiting role in migration and invasion of endometrioid endometrial carcinoma (EEC) cells by inactivating neuromedin U [31](#feb412483-bib-0031){ref-type="ref"}. Downregulated HAND2‐AS1 has been found in EEC tissues [31](#feb412483-bib-0031){ref-type="ref"}. Moreover, HAND2‐AS1 was closely associated with tumor grade, lymph node metastasis and recurrence of EEC patients and serves as a potential prognostic biomarker [31](#feb412483-bib-0031){ref-type="ref"}. A recent study indicated that HAND2‐AS1 was also downregulated in HCC tissues, which was associated with migration of HCC cells [32](#feb412483-bib-0032){ref-type="ref"}. In the present study, HAND2‐AS1 was downregulated in HCC, which provided evidence in support of the previous study. We speculate that HAND2‐AS1 might be involved with the process of HCC by inhibiting miR‐93 and miR‐244 and competing with their targets such as LRAT and RND3. Like miR‐93, ENSG00000232855 was speculated to play roles in HCC as well.

Additionally, ENSG00000232855 was a target of another HCC‐related miRNA, miR‐877. A previous study indicated that miR‐877 plays a regulating role in cell proliferation, apoptosis and the cell cycle of HCC [33](#feb412483-bib-0033){ref-type="ref"}. In this study, we highlighted the prognostic value of miR‐877 for HCC. Considering targeted DEmRNAs of miR‐877, *RCAN1* was a downregulated DEmRNA derived from the top 10 downregulated DEmRNAs in HCC in the present study. Downregulation of *RCAN1* has been found in HCC tissues. Based on the experiments *in vitro*, RCAN1 has an inhibitory role in cell proliferation, migration and invasion of HCC cells [34](#feb412483-bib-0034){ref-type="ref"}. ENSG00000232855--miR‐877--*RCAN1* interaction was speculated to play key roles in the process of HCC.

In addition, we obtained three DElncRNA--nearby target DEmRNA pairs, namely HCG25--*KIFC1*, LOC105378687--*CDC20* and LOC101927043--*EPCAM*. *KIFC1* was widely overexpressed in various cancers such as breast cancer, non‐small‐cell lung cancer and gastric cancer, and was reported to be involved with the development and prognosis of cancers [35](#feb412483-bib-0035){ref-type="ref"}, [36](#feb412483-bib-0036){ref-type="ref"}, [37](#feb412483-bib-0037){ref-type="ref"}. A recent study found that overexpressed *KIFC1* was found in HCC and was associated with shorter overall survival time of patients with HCC [38](#feb412483-bib-0038){ref-type="ref"}. Upregulated *KIFC1* was also found in HCC with both diagnostic and prognostic value for HCC in our study, which provided evidence in support of the previous study. There is no study report on the association between HCC and HCG25. *KIFC1* was a nearby target gene of HCG25 and HCG25 was significantly upregulated in HCC and has great diagnostic value for HCC. We speculate that HCG25 may regulate the process of HCC by its *cis*‐regulatory role on the expression of *KIFC1*. As one of the key genes associated with the hepatocyte cell cycle, *CDC20* has been reported to be involved with the development of HCC [39](#feb412483-bib-0039){ref-type="ref"}. Silencing *CDC20* could delay hepatocellular mitotic progression and inhibit HCC cell proliferation [40](#feb412483-bib-0040){ref-type="ref"}, [41](#feb412483-bib-0041){ref-type="ref"}. In this study, both diagnostic and prognostic values of *CDC20* for HCC were observed. EPCAM is a cell surface glycoprotein that serves as a marker of cancer stem cells. Upregulated *EPCAM* has been found in HCC tissues compared with normal liver tissues. Moreover, *EPCAM* was associated with shorter survival of patients with HCC. We speculate that LOC105378687 and LOC101927043 may play roles in the development of HCC by interacting with CDC20 and EPCAM, respectively.

Conclusions {#feb412483-sec-0022}
===========

In conclusion, our study was a comprehensive analysis of key DEmRNAs, DEmiRNAs and DElncRNAs in HCC. Based on the bioinformatics analysis, several DEmRNAs, DEmiRNAs and DElncRNAs and their interactions may play important roles in the process of HCC, which has provided clues for exploring the molecular mechanisms of HCC. Moreover, diagnostic and prognostic values of several key DEmRNAs, DEmiRNAs and DElncRNAs for HCC were found in this study, which has made a contribution toward developing potential biomarkers and therapeutic target sites for HCC.
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